Orgenesis Inc. (ORGS)
OTCMKTS
· Delayed Price · Currency is USD
2.320
-1.050 (-31.16%)
Mar 31, 2025, 1:17 PM EST
Orgenesis Employees
Orgenesis had 146 employees as of December 31, 2023. The number of employees decreased by 21 or -12.57% compared to the previous year.
Employees
146
Change (1Y)
-21
Growth (1Y)
-12.57%
Revenue / Employee
$6,158
Profits / Employee
-$235,699
Market Cap
18.09M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 116 |
American Oncology Network | 1,525 |
Orgenesis News
- 24 days ago - Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies - Accesswire
- 2 months ago - Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings - Accesswire
- 4 months ago - Orgenesis GAAP EPS of $1.93, revenue of $0.3M - Seeking Alpha
- 6 months ago - Why Orgenesis (ORGS) Stock Is Down 23% Today - Benzinga
- 6 months ago - Orgenesis announces 1-for-10 reverse stock split to regain Nasdaq compliance - Seeking Alpha
- 7 months ago - Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia - GlobeNewsWire
- 8 months ago - Orgenesis Announces Strategic Partnership with Harley Street Healthcare Group to Launch a State-of-the-Art Longevity & Wellness Initiative Globally - GlobeNewsWire
- 11 months ago - Orgenesis Provides Business Update for the First Quarter of 2024 - GlobeNewsWire